Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6144 | 1459 | 26.5 | 76% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SCINTIMAMMOGRAPHY | Author keyword | 233 | 75% | 11% | 167 |
2 | TC 99M MIBI | Author keyword | 52 | 38% | 7% | 108 |
3 | TC 99M TETROFOSMIN | Author keyword | 40 | 40% | 5% | 79 |
4 | TC 99M SESTAMIBI | Author keyword | 36 | 32% | 7% | 95 |
5 | BREAST SPECIFIC GAMMA IMAGING | Author keyword | 36 | 79% | 2% | 23 |
6 | MOLECULAR BREAST IMAGING | Author keyword | 26 | 69% | 2% | 22 |
7 | TECHNETIUM 99M TETROFOSMIN | Author keyword | 22 | 39% | 3% | 45 |
8 | TECHNETIUM 99M METHOXYISOBUTYLISONITRILE | Author keyword | 20 | 67% | 1% | 18 |
9 | TECHNETIUM 99M MIBI | Author keyword | 16 | 46% | 2% | 25 |
10 | BREAST SCINTIGRAPHY | Author keyword | 15 | 82% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SCINTIMAMMOGRAPHY | 233 | 75% | 11% | 167 | Search SCINTIMAMMOGRAPHY | Search SCINTIMAMMOGRAPHY |
2 | TC 99M MIBI | 52 | 38% | 7% | 108 | Search TC+99M+MIBI | Search TC+99M+MIBI |
3 | TC 99M TETROFOSMIN | 40 | 40% | 5% | 79 | Search TC+99M+TETROFOSMIN | Search TC+99M+TETROFOSMIN |
4 | TC 99M SESTAMIBI | 36 | 32% | 7% | 95 | Search TC+99M+SESTAMIBI | Search TC+99M+SESTAMIBI |
5 | BREAST SPECIFIC GAMMA IMAGING | 36 | 79% | 2% | 23 | Search BREAST+SPECIFIC+GAMMA+IMAGING | Search BREAST+SPECIFIC+GAMMA+IMAGING |
6 | MOLECULAR BREAST IMAGING | 26 | 69% | 2% | 22 | Search MOLECULAR+BREAST+IMAGING | Search MOLECULAR+BREAST+IMAGING |
7 | TECHNETIUM 99M TETROFOSMIN | 22 | 39% | 3% | 45 | Search TECHNETIUM+99M+TETROFOSMIN | Search TECHNETIUM+99M+TETROFOSMIN |
8 | TECHNETIUM 99M METHOXYISOBUTYLISONITRILE | 20 | 67% | 1% | 18 | Search TECHNETIUM+99M+METHOXYISOBUTYLISONITRILE | Search TECHNETIUM+99M+METHOXYISOBUTYLISONITRILE |
9 | TECHNETIUM 99M MIBI | 16 | 46% | 2% | 25 | Search TECHNETIUM+99M+MIBI | Search TECHNETIUM+99M+MIBI |
10 | BREAST SCINTIGRAPHY | 15 | 82% | 1% | 9 | Search BREAST+SCINTIGRAPHY | Search BREAST+SCINTIGRAPHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRONE SCINTIMAMMOGRAPHY | 179 | 82% | 7% | 103 |
2 | SCINTIMAMMOGRAPHY | 83 | 47% | 9% | 131 |
3 | TC 99M SESTAMIBI SCINTIMAMMOGRAPHY | 69 | 91% | 2% | 29 |
4 | TC 99M MIBI SCINTIMAMMOGRAPHY | 57 | 95% | 1% | 19 |
5 | TECHNETIUM 99M MIBI | 51 | 60% | 4% | 55 |
6 | METHOXYISOBUTYLISONITRILE | 45 | 68% | 3% | 39 |
7 | TECHNETIUM 99M MIBI SCINTIMAMMOGRAPHY | 41 | 87% | 1% | 20 |
8 | TC 99M METHOXYISOBUTYLISONITRILE | 36 | 60% | 3% | 40 |
9 | TC 99M SESTAMIBI | 36 | 18% | 12% | 175 |
10 | HEXAKIS 2 METHOXYISOBUTYLISONITRILETECHNETIUMI | 35 | 86% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Performance of SPECT in the differential diagnosis of glioma recurrence from radiation necrosis | 2015 | 1 | 41 | 39% |
Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis | 2013 | 10 | 56 | 61% |
Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature | 2003 | 42 | 65 | 89% |
The role of Tc-99m-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis | 1999 | 85 | 108 | 75% |
Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression | 2011 | 7 | 47 | 94% |
Imaging of multidrug resistance in cancer | 2011 | 14 | 35 | 49% |
Single-photon agents for tumor imaging: Tl-201, Tc-99m-MIBI, and Tc-99m-tetrofosmin | 2004 | 43 | 115 | 61% |
A meta-analysis of scintimammography: an evidence-based approach to its clinical utility | 2006 | 9 | 34 | 79% |
Clinical applications of Tc-99m-sestamibi scintimammography | 2005 | 21 | 84 | 77% |
Molecular breast imaging with gamma emitters | 2013 | 2 | 54 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BREAST IMAGING INTERVENT | 5 | 33% | 0.9% | 13 |
2 | FAR EASTERN MEM HOSP NUCL MED | 3 | 57% | 0.3% | 4 |
3 | BIOPHYS IMAGE TREATMENT | 3 | 100% | 0.2% | 3 |
4 | IST RADIOL CENT | 2 | 67% | 0.1% | 2 |
5 | DIAGNOST MED SCI | 1 | 19% | 0.5% | 7 |
6 | MOL RADIOPHARMACOL | 1 | 38% | 0.2% | 3 |
7 | ORAL MAXILLO IAL DIAGNOST SURG SCI | 1 | 38% | 0.2% | 3 |
8 | CELL DEATH NEOPLASIA GRP | 1 | 50% | 0.1% | 2 |
9 | ONCOL SENOL | 1 | 50% | 0.1% | 2 |
10 | RADIOL MOL RADIOPHARMACOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000135178 | TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//TC 99M VDMSA |
2 | 0.0000104327 | B2T//BREAST DIS UNIT//POSITRON EMISSION MAMMOGRAPHY |
3 | 0.0000092787 | C 11 METHIONINE//O 2 F 18FLUOROETHYL L TYROSINE//FET PET |
4 | 0.0000060832 | SECT RADIAT DETECT MED IMAGING//PINHOLE SPECT//PINHOLE COLLIMATOR |
5 | 0.0000053965 | SOFT TISSUES NEOPLASMS//BONE NEOPLASMS MR//MUSCLES NEOPLASMS |
6 | 0.0000051537 | JOURNAL OF NUCLEAR CARDIOLOGY//GATED SPECT//MYOCARDIAL PERFUSION IMAGING |
7 | 0.0000042109 | DEPTH OF INTERACTION//DEPTH OF INTERACTION DOI//GAMMA CAMERA SPECT PET PET CT CORONARY CT ANGIOGRAPHY CTA |
8 | 0.0000041080 | BREAST MRI//BREAST NEOPLASMS MR//MR MAMMOGRAPHY |
9 | 0.0000037273 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//PSC 833 |
10 | 0.0000036911 | PERIPHERAL ARTERY DISEASE PAD//KLIN ABDOMINALNU ENDOKRINU HIRURGIJU//ASYMPTOMATIC DIABETIC PATIENTS |